Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$252,005
-$453,089 QoQ
Shares Held
1,608
-65.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,215
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gateway Wealth Partners, LLC holds $15,922,774 across 11 Drug Manufacturers - General names. NVS ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,158 | $4,317,639 | |
| 2 | LLY |
ELI LILLY & Co
|
2,629 | $3,153,301 | |
| 3 | JNJ |
Johnson & Johnson
|
11,060 | $2,808,908 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,347 | $1,329,589 | |
| 5 | AZN |
Astrazeneca PLC
|
6,327 | $1,199,725 | |
| 6 | AMGN |
Amgen Inc
|
2,558 | $926,302 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,305 | $922,913 | |
| 8 | PFE |
Pfizer Inc
|
19,883 | $478,782 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,005 | 1,608 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $705,094 | 4,616 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||